USD 0.0
(-66.17%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 10.3 Million USD | 123.31% |
2022 | 4.61 Million USD | -12.04% |
2021 | 5.24 Million USD | 0.41% |
2020 | 5.22 Million USD | -18.62% |
2019 | 6.41 Million USD | 13.51% |
2018 | 5.65 Million USD | 0.72% |
2017 | 5.61 Million USD | 15.09% |
2016 | 4.87 Million USD | 2.61% |
2015 | 4.75 Million USD | 17.07% |
2014 | 4.06 Million USD | -4.74% |
2013 | 4.26 Million USD | -0.53% |
2012 | 4.28 Million USD | 8.91% |
2011 | 3.93 Million USD | -9.79% |
2010 | 4.36 Million USD | 8.0% |
2009 | 4.03 Million USD | -25.44% |
2008 | 5.41 Million USD | -2.98% |
2007 | 5.58 Million USD | 36.09% |
2006 | 4.1 Million USD | 74.8% |
2005 | 2.34 Million USD | 5.61% |
2004 | 2.22 Million USD | -76.47% |
2003 | 9.44 Million USD | -5.61% |
2002 | 10 Million USD | 8.81% |
2001 | 9.19 Million USD | -20.94% |
2000 | 11.63 Million USD | -12.54% |
1999 | 13.3 Million USD | 10.83% |
1998 | 12 Million USD | 36.36% |
1997 | 8.8 Million USD | 46.67% |
1996 | 6 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.6 Million USD | -53.88% |
2023 Q2 | 1.33 Million USD | -66.75% |
2023 Q4 | 3.47 Million USD | 135.05% |
2023 Q3 | 1.47 Million USD | 10.45% |
2023 FY | 10.3 Million USD | 123.31% |
2023 Q1 | 4.01 Million USD | 355.3% |
2022 FY | 4.61 Million USD | -12.04% |
2022 Q2 | 1.09 Million USD | -12.33% |
2022 Q3 | 1.38 Million USD | 25.83% |
2022 Q4 | 882.87 Thousand USD | -36.08% |
2022 Q1 | 1.25 Million USD | -8.29% |
2021 FY | 5.24 Million USD | 0.41% |
2021 Q3 | 1.5 Million USD | 55.15% |
2021 Q1 | 1.4 Million USD | 19.36% |
2021 Q2 | 968.6 Thousand USD | -31.24% |
2021 Q4 | 1.36 Million USD | -9.16% |
2020 FY | 5.22 Million USD | -18.62% |
2020 Q1 | 1.47 Million USD | -23.31% |
2020 Q2 | 1.46 Million USD | -0.67% |
2020 Q3 | 1.1 Million USD | -24.48% |
2020 Q4 | 1.18 Million USD | 6.74% |
2019 Q2 | 1.61 Million USD | 1.1% |
2019 Q3 | 1.28 Million USD | -20.47% |
2019 Q4 | 1.92 Million USD | 49.64% |
2019 FY | 6.41 Million USD | 13.51% |
2019 Q1 | 1.59 Million USD | -8.73% |
2018 FY | 5.65 Million USD | 0.72% |
2018 Q4 | 1.75 Million USD | 43.36% |
2018 Q3 | 1.22 Million USD | -5.33% |
2018 Q2 | 1.28 Million USD | -7.49% |
2018 Q1 | 1.39 Million USD | -0.41% |
2017 Q2 | 1.45 Million USD | 10.87% |
2017 Q1 | 1.31 Million USD | -11.82% |
2017 FY | 5.61 Million USD | 15.09% |
2017 Q4 | 1.39 Million USD | -2.97% |
2017 Q3 | 1.44 Million USD | -1.01% |
2016 Q3 | 724.24 Thousand USD | -45.49% |
2016 FY | 4.87 Million USD | 2.61% |
2016 Q4 | 1.49 Million USD | 105.81% |
2016 Q1 | 1.33 Million USD | 5.38% |
2016 Q2 | 1.32 Million USD | -0.46% |
2015 Q1 | 1.12 Million USD | 11.21% |
2015 Q2 | 1.3 Million USD | 15.8% |
2015 FY | 4.75 Million USD | 17.07% |
2015 Q3 | 1.06 Million USD | -18.48% |
2015 Q4 | 1.26 Million USD | 19.35% |
2014 Q2 | 1.01 Million USD | 1.08% |
2014 Q4 | 1.01 Million USD | -1.0% |
2014 FY | 4.06 Million USD | -4.74% |
2014 Q1 | 1 Million USD | -3.98% |
2014 Q3 | 1.02 Million USD | 0.13% |
2013 Q4 | 1.05 Million USD | -3.5% |
2013 Q3 | 1.08 Million USD | -3.81% |
2013 FY | 4.26 Million USD | -0.53% |
2013 Q2 | 1.13 Million USD | 14.2% |
2013 Q1 | 991.21 Thousand USD | -19.11% |
2012 Q4 | 1.22 Million USD | 26.41% |
2012 Q2 | 898.49 Thousand USD | -24.63% |
2012 Q3 | 969.44 Thousand USD | 7.9% |
2012 Q1 | 1.19 Million USD | 7.16% |
2012 FY | 4.28 Million USD | 8.91% |
2011 Q3 | 932.62 Thousand USD | -2.31% |
2011 FY | 3.93 Million USD | -9.79% |
2011 Q4 | 1.11 Million USD | 19.27% |
2011 Q2 | 954.66 Thousand USD | 2.07% |
2011 Q1 | 935.33 Thousand USD | -10.57% |
2010 Q1 | 1.11 Million USD | 8.23% |
2010 FY | 4.36 Million USD | 8.0% |
2010 Q4 | 1.04 Million USD | -7.31% |
2010 Q3 | 1.12 Million USD | 5.18% |
2010 Q2 | 1.07 Million USD | -3.8% |
2009 Q4 | 1.03 Million USD | 3.29% |
2009 FY | 4.03 Million USD | -25.44% |
2009 Q1 | 1.01 Million USD | -7.64% |
2009 Q2 | 994.89 Thousand USD | -2.12% |
2009 Q3 | 997.51 Thousand USD | 0.26% |
2008 Q3 | 1.24 Million USD | -23.23% |
2008 Q2 | 1.61 Million USD | 11.24% |
2008 FY | 5.41 Million USD | -2.98% |
2008 Q1 | 1.45 Million USD | 4.36% |
2008 Q4 | 1.1 Million USD | -11.45% |
2007 FY | 5.58 Million USD | 36.09% |
2007 Q4 | 1.39 Million USD | -5.58% |
2007 Q2 | 1.51 Million USD | 26.2% |
2007 Q1 | 1.19 Million USD | 6.09% |
2007 Q3 | 1.47 Million USD | -2.4% |
2006 Q4 | 1.13 Million USD | 35.86% |
2006 FY | 4.1 Million USD | 74.8% |
2006 Q2 | 1.12 Million USD | 10.75% |
2006 Q1 | 1.01 Million USD | 95.95% |
2006 Q3 | 832 Thousand USD | -26.04% |
2005 Q4 | 518.39 Thousand USD | 192.39% |
2005 Q2 | 876.06 Thousand USD | 105.08% |
2005 Q1 | 427.17 Thousand USD | 16.1% |
2005 FY | 2.34 Million USD | 5.61% |
2005 Q3 | -561.12 Thousand USD | -164.05% |
2004 FY | 2.22 Million USD | -76.47% |
2004 Q3 | 673.92 Thousand USD | 34.99% |
2004 Q2 | 499.24 Thousand USD | -79.23% |
2004 Q1 | 2.4 Million USD | -2.34% |
2004 Q4 | 367.94 Thousand USD | -45.4% |
2003 Q1 | 2.37 Million USD | 11.44% |
2003 FY | 9.44 Million USD | -5.61% |
2003 Q4 | 2.46 Million USD | 6.75% |
2003 Q3 | 2.3 Million USD | 0.15% |
2003 Q2 | 2.3 Million USD | -3.12% |
2002 Q2 | 2.62 Million USD | -3.47% |
2002 Q1 | 2.71 Million USD | 17.44% |
2002 FY | 10 Million USD | 8.81% |
2002 Q4 | 2.13 Million USD | -15.67% |
2002 Q3 | 2.52 Million USD | -3.7% |
2001 Q1 | 2.76 Million USD | 492.69% |
2001 Q4 | 2.31 Million USD | -1.86% |
2001 Q2 | 2.14 Million USD | -22.15% |
2001 Q3 | 2.35 Million USD | 9.77% |
2001 FY | 9.19 Million USD | -20.94% |
2000 FY | 11.63 Million USD | -12.54% |
2000 Q4 | -703.16 Thousand USD | -113.46% |
2000 Q3 | 5.22 Million USD | 46.58% |
2000 Q2 | 3.56 Million USD | 0.6% |
2000 Q1 | 3.54 Million USD | 10.75% |
1999 Q1 | 3.3 Million USD | -13.16% |
1999 Q2 | 3.2 Million USD | -3.03% |
1999 Q3 | 3.6 Million USD | 12.5% |
1999 FY | 13.3 Million USD | 10.83% |
1999 Q4 | 3.2 Million USD | -11.11% |
1998 Q4 | 3.8 Million USD | 40.74% |
1998 Q3 | 2.7 Million USD | -3.57% |
1998 Q2 | 2.8 Million USD | -22.22% |
1998 Q1 | 3.6 Million USD | 33.33% |
1998 FY | 12 Million USD | 36.36% |
1997 Q2 | 2 Million USD | 33.33% |
1997 Q1 | 1.5 Million USD | -21.05% |
1997 FY | 8.8 Million USD | 46.67% |
1997 Q4 | 2.7 Million USD | 12.5% |
1997 Q3 | 2.4 Million USD | 20.0% |
1996 Q4 | 1.9 Million USD | 35.71% |
1996 FY | 6 Million USD | 0.0% |
1996 Q3 | 1.4 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CVR Medical Corp. | - USD | -Infinity% |
BioElectronics Corporation | 740.67 Thousand USD | -1291.016% |
IR-Med Inc. | 4.89 Million USD | -110.521% |
Polarean Imaging plc | 12.24 Million USD | 15.843% |
Medical Supply International USA, Inc. | 1.32 Million USD | -680.231% |
Avitar, Inc. | 3.56 Million USD | -188.637% |
AVITA Medical, Inc. | 80.77 Million USD | 87.246% |
Manhattan Scientifics, Inc. | 703 Thousand USD | -1365.565% |
Össur hf. | 396.18 Million USD | 97.399% |
Zecotek Photonics Inc. | 3.46 Million USD | -197.648% |
QHSLab, Inc. | 961.65 Thousand USD | -971.376% |
Wellstar International, Inc. | 1.79 Million USD | -474.076% |
Össur hf. | 396.18 Million USD | 97.399% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 21.77 Million USD | 52.691% |
Escalon Medical Corp. | 5.25 Million USD | -96.221% |
Aurora Spine Corporation | 8.65 Million USD | -19.006% |
BrainsWay Ltd. | 28.01 Million USD | 63.227% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 9.56 Million USD | -7.722% |
Hamilton Thorne Ltd. | 33.57 Million USD | 69.311% |
Vivos Inc. | 2.78 Million USD | -269.663% |
MicroPort Scientific Corporation | 1.04 Billion USD | 99.017% |
Kelyniam Global, Inc. | 2.27 Million USD | -352.827% |
REMSleep Holdings, Inc. | 1.01 Million USD | -915.163% |
CYduct Diagnostics, Inc. | 435.5 Thousand USD | -2265.768% |
Nanomix Corporation | 8.36 Million USD | -23.127% |
Theraclion SA | 7.43 Million USD | -38.483% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 1.29 Million USD | -695.852% |
Positron Corporation | 1 Million USD | -922.841% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.11 Million USD | -231.236% |
Lombard Medical, Inc. | 30.29 Million USD | 65.986% |
ALR Technologies Inc. | 6.33 Million USD | -62.609% |
Stratec SE | 46.32 Million USD | 77.757% |
Vycor Medical, Inc. | 1.27 Million USD | -707.779% |
Heart Tronics, Inc. | 14.46 Million USD | 28.749% |
Nu-Med Plus, Inc. | 120.52 Thousand USD | -8448.297% |
Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -4891.265% |
SANUWAVE Health, Inc. | 14.15 Million USD | 27.193% |
VMS Rehab Systems, Inc. | 63.63 USD | -16191822.049% |
Guided Therapeutics, Inc. | 3.49 Million USD | -194.959% |
Ingen Technologies, Inc. | 1.88 Million USD | -447.381% |
Odyssey Group International, Inc. | -14.26 Million USD | 172.245% |
United American Healthcare Corporation | 59 Thousand USD | -17362.576% |
ECGI Holdings, Inc. | 407.48 Thousand USD | -2428.417% |
Capital Group Holdings, Inc. | 634.68 Thousand USD | -1523.305% |
ADM Tronics Unlimited, Inc. | 1.69 Million USD | -507.639% |
Urologix, Inc. | 10.09 Million USD | -2.09% |
Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -715.535% |
Nexeon MedSystems Inc. | 5.94 Million USD | -73.208% |
SS Innovations International, Inc. | 21.38 Million USD | 51.815% |
Qualis Innovations, Inc. | 230.24 Thousand USD | -4374.842% |
Smith & Nephew plc | 3.46 Billion USD | 99.703% |
NIOX Group Plc | 22.27 Million USD | 53.752% |
Fuse Medical, Inc. | 10.35 Million USD | 0.455% |
Broncus Holding Corporation | 38.15 Million USD | 72.994% |
Brain Scientific Inc. | 9.66 Million USD | -6.625% |
Health Logic Interactive Inc. | 60.69 Thousand USD | -16874.068% |